secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001193125-23-058235
Event type: debt
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen issues $24B in senior notes to fund Horizon Therapeutics acquisition
--------------------------------------------------------------------------

- Issued $24B aggregate principal across eight tranches (2025-2063 maturities) with rates 5.150%-5.750%.
- Net proceeds ~$23.77B after discounts and expenses; used to fund Horizon acquisition.
- If Horizon acquisition not consummated by Jan 31, 2024, notes subject to special mandatory redemption at 101% plus accrued interest.
- Bridge credit facility commitments reduced by net proceeds from this offering.
- Notes rank senior unsecured, effectively subordinated to subsidiary obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312523058235/0001193125-23-058235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312523058235/d448346d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-058235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer